Allosteric targeted drug delivery for enhanced blood-brain barrier penetration via mimicking transmembrane domain interactions
Open Access
- 10 April 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-18
Abstract
Current strategies for active targeting in the brain are entirely based on the effective interaction of the ligand with the orthosteric sites of specific receptors on the blood-brain barrier (BBB), which is highly susceptible to various pathophysiological factors and limits the efficacy of drug delivery. Here, we propose an allosteric targeted drug delivery strategy that targets classical BBB transmembrane receptors by designing peptide ligands that specifically bind to their transmembrane domains. This strategy prevents competitive interference from endogenous ligands and antibodies by using the insulin receptor and integrin αv as model targets, respectively, and can effectively overcome pseudotargets or target loss caused by shedding or mutating the extracellular domain of target receptors. Moreover, these ligands can be spontaneously embedded in the phospholipid layer of lipid carriers using a plug-and-play approach without chemical modification, with excellent tunability and immunocompatibility. Overall, this allosteric targeted drug delivery strategy can be applied to multiple receptor targets and drug carriers and offers promising therapeutic benefits in brain diseases.Keywords
This publication has 70 references indexed in Scilit:
- SiRNA delivery with exosome nanoparticlesNature Biotechnology, 2011
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomesNature Biotechnology, 2011
- Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)Journal of Drug Targeting, 2010
- Treatment of cryptococcal meningitis in Peruvian AIDS Patients using amphotericin B and fluconazoleJournal of Infection, 2008
- Computational Design of Peptides That Target Transmembrane HelicesScience, 2007
- How many drug targets are there?Nature Reviews Drug Discovery, 2006
- Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesityNature Medicine, 2004
- Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–RafJournal of Computational Chemistry, 2003
- Peptides Identify the Critical Hotspots Involved in the Biological Activation of the Insulin ReceptorJournal of Biological Chemistry, 2002
- Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion.1994